National Institutes of Health-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2013

  1. Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes

    Molecular and Cellular Endocrinology, Vol. 367, Núm. 1-2, pp. 109-115